
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
San Qi powder contains saponins called ginsenosides that inhibit platelet aggregation and reduce inflammation in blood vessels. These compounds help stop bleeding while simultaneously improving cardiovascular circulation through vasodilation mechanisms.

Reported Benefits (Provisional)
Origin & History

San Qi Powder is derived from the root of Panax notoginseng, a plant native to China. The roots are dried and ground into a fine powder for medicinal use.
Research Narrative (Provisional)
Research on Panax notoginseng suggests it may have anti-inflammatory and hemostatic effects. Some studies, including RCTs, have shown potential benefits in cardiovascular health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
San Qi Powder (Panax notoginseng powder) is not typically consumed for macronutrient value but rather for its dense bioactive compound profile. Per typical serving (1–3 g): Macronutrients (per 100 g dry powder, approximate): Protein: 4–8 g; Carbohydrates: 55–70 g (primarily starch and polysaccharides); Fat: 1–2 g; Dietary Fiber: 15–25 g; Calories: ~250–310 kcal. Key Bioactive Compounds: Panax notoginseng saponins (PNS, also called notoginsenosides) constitute 8–12% of dry weight, with major individual saponins including: Notoginsenoside R1 (~0.8–1.5%), Ginsenoside Rg1 (~2.0–3.5%), Ginsenoside Rb1 (~2.5–4.0%), Ginsenoside Re (~0.5–1.2%), Ginsenoside Rd (~0.3–0.8%). Flavonoids: Quercetin and kaempferol glycosides (~0.5–1.0% total flavonoids). Polysaccharides: Sanqi polysaccharides (SQPS) ~5–10%, exhibiting immunomodulatory activity. Dencichine (β-N-oxalyl-L-α,β-diaminopropionic acid): ~0.5–1.0%, responsible for hemostatic (blood-clotting) properties. Minerals (per 100 g): Iron: 5–10 mg; Calcium: 50–80 mg; Potassium: 200–350 mg; Magnesium: 30–60 mg; Zinc: 1–3 mg; Manganese: 2–5 mg; Phosphorus: 100–180 mg. Vitamins: Trace amounts of B-complex vitamins (B1, B2, B6); Vitamin E (tocopherols): ~1–3 mg/100 g. Amino acids: Contains all essential amino acids in small quantities; notably rich in arginine and glutamic acid. Volatile oils: ~0.1–0.2%, including β-elemene and α-guaiene, contributing mild anti-inflammatory effects. Phytosterols: β-sitosterol and stigmasterol (~0.1–0.3%), supporting cholesterol modulation. Bioavailability Notes: Oral bioavailability of ginsenoside Rg1 is relatively low (~2–5%) due to extensive first-pass metabolism and gut microbiota-mediated hydrolysis. Ginsenoside Rb1 has similarly low oral bioavailability (~1–4%) but is converted by intestinal bacteria into compound K (a more bioactive metabolite). Notoginsenoside R1 bioavailability is estimated at ~5–8%. Co-administration with warm water or mild heat processing may enhance saponin extraction and absorption. Polysaccharide fractions show improved absorption when taken on an empty stomach. Dencichine is relatively well absorbed orally. The flavonoid glycosides require deglycosylation by gut flora for optimal absorption. Fat-soluble components (phytosterols, vitamin E) benefit from co-ingestion with dietary fats.
Reported Mechanism (Provisional)
The primary ginsenosides Rb1, Rg1, and R1 in San Qi powder inhibit thromboxane A2 synthesis and block calcium channels in platelets, reducing aggregation. These compounds also activate nitric oxide synthase pathways, promoting vasodilation and improved endothelial function. The saponins modulate inflammatory cytokines like TNF-α and IL-6 while enhancing antioxidant enzyme activity.
Clinical Narrative (Provisional)
A randomized controlled trial with 240 hypertensive patients showed San Qi powder reduced systolic blood pressure by 15% over 12 weeks compared to placebo. Smaller studies (n=60-80) demonstrated improved platelet function and reduced bleeding time in patients with cardiovascular conditions. Most research consists of short-term trials lasting 8-16 weeks, with limited long-term safety data available.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







